Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Sanjiv S. Agarwala, MD
Authored Items
A New Year for Immunotherapy
By
Sanjiv S. Agarwala, MD
January 2016, Vol. 3, No. 1
Letter to Our Readers
Read More ›
Exploring the Possibilities of Manipulating the Immune System to Improve Outcomes
By
Sanjiv S. Agarwala, MD
November 2015, Vol. 2, No. 6
Letter to Our Readers
Read More ›
Enthusiasm Mounts as Immunotherapy Continues to Play a Positive Role in Many Disease States
By
Sanjiv S. Agarwala, MD
September 2015, Vol. 2, No. 5
Letter to Our Readers
Read More ›
Case: “Difficult-to-Operate” Basal Cell Carcinoma
By
Sanjiv S. Agarwala, MD
July 2015, Vol. 2, No. 4
Melanoma/Skin Cancer
Read More ›
Exploring Advances in Immunotherapy
By
Sanjiv S. Agarwala, MD
May 2015, Vol. 2, No. 3
Letter to Our Readers
Read More ›
The Reach of Immunotherapy: Focus on Glioblastoma
By
Sanjiv S. Agarwala, MD
March 2015, Vol. 2, No. 2
Letter to Our Readers
Read More ›
The Evolving Role of Immunotherapeutic Applications in Oncology
By
Sanjiv S. Agarwala, MD
January 2015, Vol. 2, No. 1
Letter to Our Readers
Read More ›
Immunotherapy: Early Success in Melanoma Provides Hope for Success in Other Cancers
By
Sanjiv S. Agarwala, MD
November 2014, Part 4
Letter to Our Readers
Read More ›
Personalized Medicine in Oncology Proudly Presents the Third Annual World Cutaneous Malignancies Congress and PMO Live: A Global Biomarkers Consortium Initiative
By
Sanjiv S. Agarwala, MD
Articles
Letter to Our Readers
Read More ›
The Evolution of Personalized Medicine in Oncology
By
Sanjiv S. Agarwala, MD
Articles
Letter to Our Readers
Read More ›
Introducing Immunotherapy in Oncology: A 4-Part Supplement Series to Personalized Medicine in Oncology
By
Sanjiv S. Agarwala, MD
April 2014, Part 1
Read More ›
Antiangiogenic Tyrosine Kinase Inhibitors and Their Diverse Spectra of Inhibitory Activity: Implications for Personalized Therapy in Renal Cell Carcinoma
By
Sanjiv S. Agarwala, MD
Articles
Kidney Cancer
Read More ›
Personalized Medicine in the Public Arena: Managing Expectations
By
Sanjiv S. Agarwala, MD
Articles
Editorial
Read More ›
The New Therapeutic Paradigm for Personalized Therapy of Melanoma
By
Sanjiv S. Agarwala, MD
Articles
Melanoma/Skin Cancer
Read More ›